# Liposomal Bupivacaine for Pain After Lumbar Fusion

> **NCT07171125** · PHASE4 · RECRUITING · sponsor: **Min Li** · enrollment: 204 (estimated)

## Conditions studied

- Postoperative Acute Pain
- Lumbar Degenerative Diseases

## Interventions

- **DRUG:** Liposomal bupivacaine (local infiltration)
- **DRUG:** ropivacaine (local infiltration)

## Key facts

- **NCT ID:** NCT07171125
- **Lead sponsor:** Min Li
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07171125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07171125, "Liposomal Bupivacaine for Pain After Lumbar Fusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07171125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*